Treatment of female sexual dysfunction

被引:12
|
作者
Ragucci, KR
Culhane, NS
机构
[1] Med Univ S Carolina, Dept Pharm Practice, Charleston, SC 29425 USA
[2] Med Univ S Carolina, Dept Family Med, Charleston, SC 29425 USA
[3] Wilkes Univ, Nesbitt Sch Pharm, Dept Pharm Practice, Wilkes Barre, PA 18766 USA
关键词
estrogen; female sexual dysfunction; testosterone;
D O I
10.1345/aph.1C392
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To review the pathophysiology and psychology of female sexual dysfunction (FSD) and describe potential prevention and treatment strategies for the disorder. DATA SOURCES: Articles identified from a MEDLINE search (1 966-June 2002) using the term female sexual dysfunction. Additional references were obtained from cross referencing retrieved articles. STUDY SELECTION AND DATA EXTRACTION: After evaluating various review articles, clinical trials, and investigational studies, all information that was deemed relevant by the reviewers was included. DATA SYNTHESIS: FSD is a multicausal and multidimensional problem combining biological, psychological, and interpersonal factors. The American Foundation for Urological Disease classifies FSD into 4 broad categories: sexual desire disorders, arousal disorder, orgasmic disorder, and sexual pain disorders. Depending on specific individual characteristics and category of disorder, a variety of potential treatments are available. Pharmacists can play a role in identifying and managing medication-related adverse effects that may be exacerbating FSD and educating women on treatment modalities. CONCLUSIONS: FSD is a complicated disorder that is often difficult to identify, classify, and treat appropriately. Pharmacists should have an understanding of the potential causes of FSD and the treatment options available so that they may make appropriate recommendations and counsel women effectively.
引用
收藏
页码:546 / 555
页数:10
相关论文
共 50 条
  • [1] Medical Treatment of Female Sexual Dysfunction
    Nappi, Rossella E.
    Tiranini, Lara
    Martini, Ellis
    Bosoni, David
    Righi, Alessandra
    Cucinella, Laura
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 2022, 49 (02) : 299 - 307
  • [2] Female sexual dysfunction: Evaluation and treatment
    Phillips, NA
    [J]. AMERICAN FAMILY PHYSICIAN, 2000, 62 (01) : 127 - 136
  • [3] PROGRESS IN THE TREATMENT OF FEMALE SEXUAL DYSFUNCTION
    MATHEWS, A
    [J]. JOURNAL OF PSYCHOSOMATIC RESEARCH, 1983, 27 (02) : 165 - 173
  • [4] Diagnosis and treatment of female sexual dysfunction
    Frank, Jennifer E.
    Mistretta, Patricia
    Will, Joshua
    [J]. AMERICAN FAMILY PHYSICIAN, 2008, 77 (05) : 635 - 642
  • [5] TREATMENT OPTIONS FOR FEMALE SEXUAL DYSFUNCTION
    El Kak, Faysal
    [J]. JOURNAL OF SEXUAL MEDICINE, 2015, 12 : 303 - 303
  • [7] Assessment and treatment of male and female sexual dysfunction
    Hilz, M.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E499 - E499
  • [8] Designing drugs for the treatment of female sexual dysfunction
    Brown, Alan D.
    Blagg, Julian
    Reynolds, David S.
    [J]. DRUG DISCOVERY TODAY, 2007, 12 (17-18) : 757 - 766
  • [9] Melanocortins in the treatment of male and female sexual dysfunction
    Shadiack, Annette M.
    Sharma, Shubh D.
    Earle, Dennis C.
    Spana, Carl
    Hallam, Trevor J.
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (11) : 1137 - 1144
  • [10] History of the Treatment of Female Sexual Dysfunction (s)
    Kleinplatz, Peggy J.
    [J]. ANNUAL REVIEW OF CLINICAL PSYCHOLOGY, VOL 14, 2018, 14 : 29 - 54